Advertisement
Screener

SUTRO BIOPHARMA, INC. (STRO) Pre-Tax Margin

SUTRO BIOPHARMA, INC. (STRO) Pre-Tax Margin

  • 2026-06-30: Pre-Tax Margin -391.63%.
  • 2026-03-31: Pre-Tax Margin -265.09%.
  • 2025-12-31: Pre-Tax Margin -402.20%.
  • 2025-09-30: Pre-Tax Margin -586.58%.

Complete source-backed pre-tax margin history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-06-30-391.63%
2026-03-31-265.09%
2025-12-31-402.20%
2025-09-30-586.58%
2025-06-30-18.07%
2025-03-31-436.58%
2024-12-31-473.28%
2024-09-30-572.62%
2024-06-30-186.77%
2024-03-31-447.52%
2023-12-3141.22%
2023-09-30-280.34%
2023-06-30-368.55%
2023-03-31-391.79%
2022-12-31-400.76%
2022-09-30-77.50%
2022-06-30-83.68%
2022-03-31-663.22%
2021-12-31-357.85%
2021-09-30-362.83%
2021-06-30-21.93%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-31-186.55%
2024-12-31-362.81%
2023-12-31-57.63%
2022-12-31-172.20%
2021-12-31-170.55%
2020-12-31-74.96%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Invivyd, Inc. (IVVD)United States$0.270B-2.42
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Liminatus Pharma, Inc. (LIMN)United States$0.282B
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87